 |
인쇄하기
취소
|
Lipitor patients warned of liver dysfunction
The Korea Food and Drug Administration (KFDA) announced on July 4 improved labeling for Pfizer Korea's Lipitor tablets (atorvastatin calcium), which have been linked to reports of adverse reactions, such as liver dysfunction, jaundice, and hepatitis.
The KFDA said it is recommended that liver function tests be performed prior to and at 12 weeks following both the initiation of therapy and an...
The KFDA said it is recommended that liver function tests be performed prior to and at 12 weeks following both the initiation of therapy and an...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.